Güney Eskiler, Gamze; Gulsah Cecener; Berrin Tunca; Unal Egeli
(SPRINGER, 2016)
The development of resistance to tamoxifen (Tam) remains a challenging clinical problem for ER+ breast cancer patients. To understand the mechanisms underlying of resistance, previous studies have driven the acquisition ...